These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7357176)

  • 1. Regional changes in brain dopamine receptor function during six months trifluoperazine administration to rats [proceedings].
    Clow A; Jenner P; Marsden CD; Theodorou A
    Br J Pharmacol; 1980 Jan; 68(1):163P-164P. PubMed ID: 7357176
    [No Abstract]   [Full Text] [Related]  

  • 2. Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings].
    Clow A; Jenner P; Marsden CD
    Br J Pharmacol; 1978 Nov; 64(3):414P. PubMed ID: 719266
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain.
    Theodorou A; Gommeren W; Clow A; Leysen J; Jenner P; Marsden CD
    Life Sci; 1981 Apr; 28(14):1621-7. PubMed ID: 7242249
    [No Abstract]   [Full Text] [Related]  

  • 5. Location of receptors mediating hypothermia after injection of dopamine agonists in rats [proceedings].
    Cox B; Lee TF
    Br J Pharmacol; 1977 Mar; 59(3):467P-468P. PubMed ID: 843709
    [No Abstract]   [Full Text] [Related]  

  • 6. A new centrally acting DA-receptor agonist with selectivity for autoreceptors.
    Hjorth S; Carlsson A; Lindberg P
    Psychopharmacol Bull; 1980 Jul; 16(3):85-90. PubMed ID: 7403415
    [No Abstract]   [Full Text] [Related]  

  • 7. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity.
    Widzowski DV; Finkelstein JN; Pokora MJ; Cory-Slechta DA
    Neurotoxicology; 1994; 15(4):853-65. PubMed ID: 7715856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI.
    Chen YI; Choi JK; Jenkins BG
    Synapse; 2005 Feb; 55(2):80-8. PubMed ID: 15529335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of stelazine on oxygen consumption and glycolytic activity on brain tissue].
    Filippov SP; Zakharov SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(1):103-11. PubMed ID: 5651467
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of stelazine on oxygen consumption and glycolytic activity on brain tissue].
    Filippov SP; Zakharov SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(1):108-11. PubMed ID: 5647154
    [No Abstract]   [Full Text] [Related]  

  • 11. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
    Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of (+/-)12-chloroscoulerine on brain dopamine receptors].
    Chen LJ; Xi Y; Pang DW; Zhou QT; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):185-9. PubMed ID: 9772676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT and DA receptor affinity of arylpiperazine derivatives with terminal benzamide fragment.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Lograno MD; Daniele E; Govoni S
    Farmaco; 1994 Sep; 49(9):567-72. PubMed ID: 7811352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin inhibitor trifluoperazine attenuates the development and expression of morphine-induced conditioned place preference in rats.
    Ye XF; Lu Y; Zhang P; Liang JH
    Eur J Pharmacol; 2004 Feb; 486(3):265-71. PubMed ID: 14985048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of chlorpromazine on dopaminergic receptor functions in rat brain--difference of the response of several dopaminergic systems after chronic administration (author's transl)].
    Kaneno S
    Seishin Shinkeigaku Zasshi; 1980 Jun; 82(6):335-52. PubMed ID: 7465695
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in dopamine receptor status after denervation or chronic receptor stimulation [proceedings].
    Costall B; Naylor RJ
    Br J Pharmacol; 1979 Jul; 66(3):492P-493P. PubMed ID: 526763
    [No Abstract]   [Full Text] [Related]  

  • 18. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.
    Breese GR; Knapp DJ; Criswell HE; Moy SS; Papadeas ST; Blake BL
    Brain Res Brain Res Rev; 2005 Feb; 48(1):57-73. PubMed ID: 15708628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
    Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
    Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of dietary administration of Lathyrus sativus pulse on behaviour, neurotransmitter receptors and membrane permeability in rats and guinea pigs.
    Amba A; Seth K; Ali M; Das M; Agarwal AK; Khanna SK; Seth PK
    J Appl Toxicol; 2002; 22(6):415-21. PubMed ID: 12424745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.